Bhella S, Wilkin AM, Hueniken K, Vijenthira A, et al. COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignancies. Vaccine 2024 Jun 28:S0264-410X(24)00715-1. doi: 10.1016/j.vaccine.2024.
PMID: 38944577